针对幼儿的商业乳制品的研究:一个范围审查
Maria Birman Cavalcanti1, Isabela da Costa Gaspar da Silva2, Fernando Lamarca3
1Social Medicine Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Maternal & child nutrition
|July 2, 2024
概括
本综述对用于幼儿的商业乳制品 (CMF 12-36) 的文献进行了映射. 工业参与是常见的,在研究解释中需要考虑潜在的利益冲突.
科学领域:
- * 营养科学 营养科学
- * * 公共卫生 公共卫生
- * 食品科学 食品科学
背景情况:
- * 商业乳制品适用于12-36个月的儿童 (CMF 12-36) 是广泛消费的.
- *了解CMF 12-36周围的研究环境对于为政策和消费者指导提供信息至关重要.
研究的目的:
- *对CMF 12-36.6的出版物进行范围审查.
- *绘制现有文献的地图,确定关键概念,并分析研究主题随时间的演变.
- * 评估商业配方奶粉行业参与程度和资金透明度.
主要方法:
- * 对科学文献进行范围审查.
- * 选了3329篇文章,其中包括220篇,1986年至2024年间发表的文章.
- *分析出版趋势,研究重点,产品名称和行业参与.
主要成果:
- *大多数出版物 (70%) 出现在2016年以后,主要来自高收入国家.
- *研究主要集中在养实践和产品成分/污染方面,自2000年代末以来,对营销和政策的兴趣越来越大.
- * 在41.8%的工程中,工业参与被注意到,经常缺乏明确的利益冲突或资金披露 (22.5%和25.5%).
结论:
- * 在过去十年中,对CMF 12-36的研究量和范围显著增加.
- * 商业配方奶粉行业的参与很普遍,由于潜在的既得利益,需要对研究进行批判性评估.
- * 进一步的研究应优先考虑资金和行业关系的透明度,以确保公正的调查结果.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...


